To evaluate the usefulness of tobacco markers in dependent smokers bei
ng treated with transdermal nicotine patchs, a study was conducted at
the Tobacco Withdrawal Consultation Centre at the Hopital Laennec, Par
is, France. 125 patients were included in the study and, in a first ti
me, carbon monoxide in exhaled air, carboxyhaemoglobin, urinary nicoti
ne and cotinine, Fagerstrom index, were measured and correlated to the
amount of nicotine inhaled per day. The most significant value was ob
served for cotinine. In a second time, 25 patients were followed up cl
inically and biologically with urinary cotinine monitoring (group FC)
and 73 were followed up only clinically (group FC). The success rate o
f therapy 12 weeks after the end of treatment was 72 % in group FB and
28 % in group FC, The nicotine patch dose was positively correlated (
p<0.01) with successful outcome. The lower the urinary cotinine level
at 4 weeks, the more likely was successful outcome (p<0.05). If psycho
logical factors remain important, urinary cotinine monitoring in the c
ourse of nicotine patch treatment thus favours successful withdrawal.